Tickwind
TodayOpportunitiesMarketsAI Chat
EN
Log inSign up
Tickwind

Read every tick. See where the market's blowing.

  • X
  • TelegramChinese
  • Newsletter

Product

  • Markets
  • Theme Zones
  • All stocks
  • Compare
  • Hot stocks
  • Opportunities
  • News
  • Discussion
  • Watchlist
  • What's new

Account

  • Settings
  • Newsletter
  • For writers
  • MCP server
  • Contact
  • Log in
  • Sign up
MarketsTheme ZonesAll stocksCompareHot stocksOpportunitiesNewsDiscussionWatchlistWhat's newSettingsNewsletterFor writersMCP serverContactLog inSign up

© 2026 Tickwind. Not investment advice.

Made for the curious investor.

Home/FTH/Capital expenditures

Faeth Therapeutics, Inc. (FTH) Capital expenditures 2020–2025

Faeth Therapeutics, Inc. (FTH) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.

$16,000FY2025 · since FY2020: $1.2M → $16,000
202122232425
Fiscal yearValueYoY
FY2025$16,000-89.0%
FY2024$146,000-18.9%
FY2023$180,000-43.9%
FY2022$321,000-84.2%
FY2021$2.0M+68.0%
FY2020$1.2M—

Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.

Source: SEC XBRL filings · For reference only · Not investment advice

More FTH financial trends

FTH RevenueFTH Net incomeFTH Net marginFTH Gross profitFTH Gross marginFTH Operating incomeFTH Operating marginFTH Operating cash flowFTH Free cash flowFTH Return on equityFTH Stock buybacksFTH Dividends paidFTH Total assetsFTH Total liabilitiesFTH Shareholders’ equityFTH overview →